(Q36068263)

12 August 2017

1 reference

title

Origins and molecular pathology of ovarian cancer (English)

1 reference

12 August 2017

0 references

1 reference

Debra A Bell

1

1 reference

12 August 2017

language of work or name

1 reference

1 February 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

18 Suppl 2

1 reference

12 August 2017

page(s)

S19-32

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800306

12 August 2017

exact match

0 references

cites work

Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

Diverse tumorigenic pathways in ovarian serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

Extrauterine Mesodermal (Müllerian) Adenosarcoma: A Clinicopathologic Analysis of Five Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

Mutational analysis of beta-catenin gene in Japanese ovarian carcinomas: frequent mutations in endometrioid carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

Artefactual loss of human ovarian surface epithelium: potential clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Histopathologic Features of Ovaries at Increased Risk for Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian dysplasia. A study of identical twins

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Early de novo ovarian carcinoma. A study of fourteen cases.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Cul-de-sac puncture in the diagnosis of early ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

PRECLINICAL DETECTION OF OVARIAN CANCER

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

p53 protein expression in putative precursor lesions of epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Interactive morphometric procedures and statistical analysis in the diagnosis of ovarian dysplasia and carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens fromBRCA1 heterozygotes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Histological features of the contralateral ovary in patients with unilateral ovarian cancer: a case control study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Is ovarian cancer associated with an increased frequency of germinal inclusion cysts?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Six families prone to ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Atypical Epithelial Proliferation in Fallopian Tubes in Prophylactic Salpingo-oophorectomy Specimens from BRCA1 and BRCA2 Germline Mutation Carriers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Women harboring BRCA1/2 germline mutations are at risk for breast and female adnexal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Cell cycle and apoptotic proteins in relation to ovarian epithelial morphology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

p53 expression in ovarian borderline tumors and stage I carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

p53 gene mutation in human borderline epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Frequency of BRCA1 dysfunction in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Inactivation of BRCA1 and BRCA2 in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ultrasound screening for familial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Genetic analysis of benign ovarian tumors.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Changes in gene expression during progression of ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Molecular pathology of ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

k-ras mutation may be an early event in mucinous ovarian tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Cancer risk after a hospital discharge diagnosis of endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

The development of malignancy in endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Carcinoma of the ovary and endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Endometrioid tumours of the ovary

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Endometrioid carcinoma of the ovary.A clinicopathologic study of 75 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Malignant transformation in ovarian endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Endometrioid and clear cell carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

The pathological assessment of ovarian neoplasms. i: introduction to the common ‘epithelial’ tumours and analysis of benign ‘epithelial’ tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian endometrioid tumors of low malignant potential: a clinicopathologic study of 30 cases with comparison to well-differentiated endometrioid adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian tumors associated with atypical endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Histologic transformation of benign endometriosis to early epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian atypical endometriosis: its close association with malignant epithelial tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Epithelial Abnormalities in Cystic Ovarian Endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Ovarian endometriotic cysts. An analysis of cytologic atypia and DNA ploidy patterns

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Nucleolar organizer regions in endometriosis, atypical endometriosis, and clear cell and endometrioid carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Monoclonal origin of endometriotic cysts

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Molecular analysis of clonality in ovarian endometrial cysts

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Analysis of p53 and ras gene mutations in endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800306

7 January 2021

10.1038/MODPATHOL.3800306

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1027289274

0 references

1 reference